Notícias e Atividades da Neumora

Neumora é uma das ...

• Russell 3000;
• TOB Iconic 10,000.

Neumora é uma empresa listada sob o símbolo NMR (US).

Veja o organograma con seus 26 executivos principais

Biografias mais buscadas da Neumora

• Paul Berns, Chairman of the Board and Chief Executive Officer
• David Piacquad, Director
• Maykin Ho, Director

Recentes movimentos de executivos em Neumora

• David Phillips, ingressou na Companhia como Senior Vice President of Quality  (Notícia publicada em 22 de abril de 2026).

Criar um alerta
para seguir os movimentos de executivos da Neumora.

Neumora possui 2.428 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).

Popular M&A news in Biotecnologia

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (publicado em 15 de julho de 2026).

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Robert Gould - Board Member da Fulcrum Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Neumora

• Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder  - Neumora
• Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer - Neumora
• Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer - Neumora
• Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder  - Neumora
• Brain disease startup Neumora draws more funding for ambitious research plan
• Neumora Therapeutics Announces $112 Million Series B Financing - Neumora
• Neumora Therapeutics Announces $112 Million Series B Financing - Neumora
• Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases - Neumora
• Neumora Therapeutics Launches to Pioneer a New Era of Precision Medicines for Brain Diseases - Neumora
• Neumora Expands Precision Neuroscience Pipeline with Novel M4 Receptor Modulator Program Through Exclusive License Agreement with Vanderbilt University - Neumora
• View more press releases Close

Redes sociais sobre Neumora

• Neumora na Wikipedia, Google News e Yahoo Finance
• Neumora na LinkedIn, X (Twitter) e YouTube